Innate Pharma Defensive Interval Ratio
Innate Pharma defensive interval ratio. Innate Pharma (IPHA) has a Defensive Interval Ratio of 185 days as of March 2026. Defensive assets of $18.61 Million (cash $-, short-term investments $6.22 Million, receivables $12.39 Million) cover 185 days of daily cash needs of $100.37K/day. See Innate Pharma short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of Innate Pharma (2005–2025)
Defensive interval ratio of Innate Pharma from 2005 to 2025. This chart shows how Innate Pharma's Defensive Interval Ratio has evolved across 20 annual periods from 2005 to 2025. As of March 2026, the ratio stands at 185 days, meaning defensive assets of $18.61 Million can fund 185 days of operations without new revenue. Check IPHA financial resilience to evaluate the company's liquid asset resilience ratio.
Innate Pharma Defensive Interval Ratio by Year (2005–2025)
Innate Pharma defensive interval ratio by year from 2005 to 2025. The table below presents the year-by-year Defensive Interval Ratio for Innate Pharma from 2005 to 2025, covering 20 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see balance sheet size of Innate Pharma.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 185 days | $18.61 Million | $100.37K/day | $- | $6.22 Million | ▲ +8 days |
| 2024 | 177 days | $16.02 Million | $90.36K/day | $- | $14.37 Million | ▼ -452 days |
| 2023 | 629 days | $68.34 Million | $108.59K/day | $- | $21.85 Million | ▲ +449 days |
| 2022 | 180 days | $20.40 Million | $113.25K/day | $- | $17.26 Million | ▲ +99 days |
| 2021 | 81 days | $17.74 Million | $218.87K/day | $- | $16.08 Million | ▼ -129 days |
| 2020 | 210 days | $26.17 Million | $124.62K/day | $- | $14.85 Million | ▲ +154 days |
| 2019 | 56 days | $18.79 Million | $333.76K/day | $- | $15.98 Million | ▼ -244 days |
| 2018 | 300 days | $161.85 Million | $539.01K/day | $- | $15.22 Million | ▲ +143 days |
| 2017 | 157 days | $31.83 Million | $202.49K/day | $- | $16.74 Million | ▼ -69 days |
| 2016 | 226 days | $47.34 Million | $209.43K/day | $- | $21.78 Million | ▼ -338 days |
| 2015 | 564 days | $92.99 Million | $164.83K/day | $- | $83.04 Million | ▲ +363 days |
| 2014 | 201 days | $5.93 Million | $29.52K/day | $- | $4.95 Million | ▼ -11 days |
| 2013 | 212 days | $5.39 Million | $25.42K/day | $- | $2.99 Million | ▲ +94 days |
| 2012 | 118 days | $4.98 Million | $42.09K/day | $- | $2.03 Million | ▼ -271 days |
| 2010 | 390 days | $7.87 Million | $20.20K/day | $- | $2.76 Million | ▲ +3 days |
| 2009 | 387 days | $9.82 Million | $25.38K/day | $- | $2.75 Million | ▼ -661 days |
| 2008 | 1048 days | $36.81 Million | $35.12K/day | $- | $22.95 Million | ▼ -704 days |
| 2007 | 1752 days | $50.62 Million | $28.89K/day | $- | $48.30 Million | ▼ -450 days |
| 2006 | 2202 days | $60.54 Million | $27.50K/day | $- | $53.66 Million | ▼ -343 days |
| 2005 | 2545 days | $15.76 Million | $6.19K/day | $- | $15.76 Million | — |